Global Cell Culture Market by Product, Application, End-user and Region - Forecast to 2025

DUBLIN, Dec. 18, 2020 /PRNewswire/ -- The "Global Cell Culture Market by Product (Consumables [Media, Serum, Vessels], Equipment [Bioreactor, Centrifuge, Incubator, Autoclave]), Application (Therapeutic Proteins, Vaccines, Diagnostics, Stem Cells), End-user (Pharma, Biotech) and Region - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global cell culture market is projected to reach USD 33.1 billion by 2025 from USD 19 billion in 2020, at a CAGR of 11.8% during the forecast period.

The growth of this market is majorly driven by the growing awareness about the benefits of cell culture-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, and the launch of advanced cell culture products. On the other hand, the high cost of cell biology research and the lack of proper infrastructure for cell-based research activities are the major factors restraining this market's growth.

Based on product, the consumables segment holds the largest market share during the forecast period

Based on product, the cell culture market is segmented into equipment and consumables. The consumables segment accounted for the largest market share in 2019 and is expected to register the highest CAGR during the forecast period. The dominant share and high growth of the consumables segment can be attributed to the repeated purchase of consumables and increased funding for cell-based research.

Based on application, the biopharmaceutical production segment is expected to register the highest CAGR during the forecast period

Based on application, the cell culture market is categorized into biopharmaceutical production, stem cell research, diagnostics, drug screening & development, tissue engineering and regenerative medicine, and other applications. The biopharmaceutical production application segment is expected to register the highest CAGR during the forecast period.The high growth of this segment is attributed to the commercial expansion of major pharmaceutical companies, growing regulatory approvals for the production of cell culture-based vaccines, and the increasing demand for monoclonal antibodies (mAbs).

Pharmaceutical & Biotechnology companies end-user segment is expected to grow at the highest CAGR in the cell culture market during the forecast period

Based on end-users, the cell culture market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospitals and diagnostic centers, and cell banks. The pharmaceutical & biotechnology companies segment is expected to witness the highest growth during the forecast period. The growing use of single-use technologies, the increasing number of regulatory approvals for cell culture-based vaccines, and the presence of a large number of pharmaceutical players in this market are some of the factors driving the cell culture market for this end-user segment.

North America is expected to account for the largest share of the cell culture market in 2019

In 2019, North America accounted for the largest share of the cell culture market, followed by Europe, the Asia-Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be attributed to the growing regulatory approvals for cell culture-based vaccines, technological advancements, and growth in the biotechnology & pharmaceutical industries in the region are the key factors driving the growth of the cell culture market in North America.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Cell Culture: Market Overview
4.2 Asia-Pacific: Cell Culture Market Share, by End-user and Country (2019)
4.3 Cell Culture Market: Geographic Growth Opportunities
4.4 Regional Mix: Cell Culture Market
4.5 Cell Culture Market: Developed Vs. Developing Markets

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Growing Awareness About the Benefits of Cell Culture-Based Vaccines
5.2.1.2 Increasing Demand for Monoclonal Antibodies
5.2.1.3 Funding for Cell-Based Research
5.2.1.4 Growing Preference for Single-Use Technologies
5.2.1.5 Launch of Advanced Cell Culture Products
5.2.1.6 Growing Focus on Personalized Medicine
5.2.2 Market Restraints
5.2.2.1 High Cost of Cell Biology Research
5.2.2.2 Lack of Infrastructure for Cell-Based Research in Emerging Economies
5.2.3 Market Opportunities
5.2.3.1 Growing Demand for 3D Cell Culture
5.2.3.2 The Growing Risk of Pandemics and Communicable Diseases
5.2.3.3 Emerging Economies
5.3 COVID-19 Impact on the Cell Culture Market
5.4 Value Chain Analysis
5.5 Supply Chain Analysis
5.6 Ecosystem Analysis
5.7 Regulatory Analysis

6 Cell Culture Market, by Product
6.1 Introduction
6.2 Impact of the COVID-19 on the Cell Culture Market
6.3 Consumables
6.3.1 Sera, Media, and Reagents
6.3.1.1 Media
6.3.1.1.1 Serum-Free Media
6.3.1.1.1.1 Lack of Sera Eliminates the Risk of Contamination by Viruses
6.3.1.1.2 Classical Media & Salts
6.3.1.1.2.1 Classical Media is Commonly Used in Virology, Vaccine Production, and Primary Tissue Explant Culture
6.3.1.1.3 Stem Cell Culture Media
6.3.1.1.3.1 Stem Cell Culture Media to Witness the Highest Growth in the APAC Market During the Forecast Period
6.3.1.1.4 Specialty Media
6.3.1.1.4.1 Specialty Media is Suitable for the Growth of Selective Cell Types
6.3.1.2 Reagents
6.3.1.2.1 Growth Factors
6.3.1.2.1.1 Growth Factors are Unique Cell Signaling Molecules That Help in Cell Proliferation & Development
6.3.1.2.2 Supplements
6.3.1.2.2.1 Supplements Such as Amino Acids Play a Key Role in Inducing Cell Growth
6.3.1.2.3 Buffers & Chemicals
6.3.1.2.3.1 Chemical Buffers are Widely Used, But It Can be Toxic at Higher Concentrations
6.3.1.2.4 Cell Dissociation Reagents
6.3.1.2.4.1 Dissociation Reagents Can be Enzymatic or Non-Enzymatic
6.3.1.2.5 Balanced Salt Solutions
6.3.1.2.5.1 Balanced Salt Solutions Find Wide Applications in Life Sciences
6.3.1.2.6 Attachment & Matrix Factors
6.3.1.2.6.1 The Development of Cells is Dependent on Attachment Factors
6.3.1.2.7 Antibiotics/Antimycotics
6.3.1.2.7.1 The Possibility of Contamination Risks Make the Long-Term Use of Antibiotics/Antimycotics Conditional
6.3.1.2.8 Contamination Detection Kits
6.3.1.2.8.1 Contamination Detection Kits Provide Rapid Results
6.3.1.2.9 Cryoprotective Reagents
6.3.1.2.9.1 Cryoprotective Reagents Protect Tissues/Cells from Damage due to Freezing
6.3.1.2.10 Other Cell Culture Reagents
6.3.1.3 Sera
6.3.1.3.1 Fetal Bovine Sera (FBS)
6.3.1.3.1.1 Use of FBS is Now Restricted due to Regulatory Guidelines
6.3.1.3.2 Adult Bovine Sera (ABS)
6.3.1.3.2.1 ABS is a Cost-Effective Alternative to FBS and is Used as a Biochemical Reagent in IVD
6.3.1.3.3 Other Animal Sera
6.3.2 Vessels
6.3.2.1 Roller/Roux Bottles
6.3.2.1.1 Roller Bottles Offer an Economical Means of Cultivating Large Cell Volumes
6.3.2.2 Cell Factory Systems/Cell Stacks
6.3.2.2.1 Cell Stacks Require Special Handling Equipment and Skilled Expertise
6.3.2.3 Multiwell Plates
6.3.2.3.1 Larger Well Formats Allow for Greater Culture Volumes
6.3.2.4 Flasks
6.3.2.4.1 Disposable Flasks are in Greater Demand Among End-users
6.3.2.5 Petri Dishes
6.3.2.5.1 The Wide Usage of Petri Dishes is Attributed to Ease of Use
6.3.3 Bioreactor Accessories
6.4 Equipment
6.4.1 Supporting Equipment
6.4.2 Bioreactors
6.4.3 Storage Equipment

7 Cell Culture Market, by Application
7.1 Introduction
7.2 Impact of the COVID-19 on the Cell Culture Market
7.3 Biopharmaceutical Production
7.3.1 Therapeutic Proteins
7.3.1.1 Growing Applications of Recombinant Proteins to Drive the Growth of this Segment
7.3.2.1 Rising Incidence of Disease Outbreaks to Drive the Market Growth for Vaccine Production
7.4 Diagnostics
7.4.1 The Growing Risk of Viral Infections Drives the Uptake of Cell Culture Products for Diagnostics
7.5 Drug Screening & Development
7.5.1 Increasing Adoption of Cell-Based Assays in R&D Activities to Drive Segment Growth
7.6 Stem Cell Research
7.6.1 Increasing Stem Cell Research Activities & Investments Drive Segment Growth
7.7 Tissue Engineering and Regenerative Medicine
7.7.1 Increasing Funding for Regenerative Medicine Boosts Segment Growth
7.8 Other Applications

8 Cell Culture Market, by End-user
8.1 Introduction
8.2 Impact of the COVID-19 on the Cell Culture End-User Market
8.3 Pharmaceutical & Biotechnology Companies
8.3.1 Growing Regulatory Approvals for Cell-Culture Based Vaccines Drives Segment Growth
8.4 Hospitals and Diagnostic Laboratories
8.4.1 Increasing Applications of Cell Culture for the Diagnosis of Various Diseases to Drive Segment Growth
8.5 Research & Academic Institutes
8.5.1 Increasing Government Funding for Research Projects and the High Prevalence of Cancer to Drive Growth for this End-User Segment
8.6 Cell Banks
8.6.1 Increasing Awareness of Preserving Stem Cells to Drive Segment Growth

9 Cell Culture Market, by Region
9.1 Introduction
9.2 COVID-19 Impact on the Cell Culture Market
9.3 North America
9.5 Asia-Pacific
9.6 Latin America
9.7 Middle East and Africa

10 Competitive Landscape
10.1 Overview
10.2 Competitive Scenario
10.2.1 Partnerships, Agreements, and Collaborations (2020)
10.2.2 Product Launches & Upgrades (2020)
10.2.3 Expansions (2020)
10.2.4 Acquisitions (2019-2020)

11 Company Evaluation Matrix and Company Profiles
11.1 Company Evaluation Matrix Definition & Methodology
11.2 Competitive Leadership Mapping (2019)
11.2.1 Stars
11.2.2 Emerging Leaders
11.2.3 Pervasive Companies
11.2.4 Emerging Companies
11.3 Market Share Analysis, 2019
11.4 Company Profiles
11.4.1 Thermo Fisher Scientific Inc.
11.4.2 Merck KGaA
11.4.3 Becton, Dickinson & Company
11.4.4 Corning Incorporated
11.4.5 Danaher Corporation
11.4.6 Eppendorf AG
11.4.7 Fujifilm Irvine Scientific, Inc. (Acquired by Fujifilm Corporation)
11.4.8 Lonza Group AG
11.4.9 Sartorius AG
11.4.10 Cellgenix GmbH
11.4.11 Miltenyi Biotec
11.4.12 Stemcell Technologies, Inc.
11.4.13 Himedia Laboratories
11.4.14 Invivogen
11.4.15 Infors AG
11.4.16 Promocell
11.4.17 Pan Biotech GmbH
11.4.18 Seracare Life Sciences Incorporation
11.4.19 Caisson Labs
11.4.20 Solida Biotech GmbH

12 Appendix
12.1 Insights from Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: The Subscription Portal
12.4 Available Customizations

For more information about this report visit https://www.researchandmarkets.com/r/ea1loc

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com